Advertisement Johnson & Johnson Q1 net earnings decrease - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Johnson & Johnson Q1 net earnings decrease

Johnson & Johnson has reported net earnings of $3.5 billion, or $1.26 per diluted share, for the first quarter of 2009, a decrease of 2.5%, compared to $3.6 billion, or $1.26 per diluted share, for the same period in 2008.

The company has reported sales of $15 billion for the first quarter of 2009, a decrease of 7.2%, compared to $16.19 billion for the first quarter of 2008.

William Weldon, chairman and CEO of Johnson & Johnson, said: “Despite challenging economic and near-term business pressures, we continue to deliver solid financial results. We are continuing to make strategic investments in order to bring important new products to market, positioning us well for long-term growth.”